---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-22-001432"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2022-12-20T23:59:59+00:00"
generated_at: "2026-06-21T01:32:04.344812+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# IGC posts updated life sciences presentation on website; no financial or clinical updates

## Summary
- Presentation covers low-dose THC drug formulation and disease treatment initiatives.
- Also highlights cannabinoid consumer product lines including Holief and Sunday Seltzer.
- No new clinical trial results, partnerships, or revenue guidance disclosed.
- Presentation available at igcpharma.com and filed as Exhibit 99.1.

## SEC filing metadata
- accession: 0001185185-22-001432
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2022-12-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001432/0001185185-22-001432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001432/indiaglob20221219_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-22-001432
- JSON: https://secwatch.observer/filing/0001185185-22-001432.json
- Plain text: https://secwatch.observer/filing/0001185185-22-001432.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.